Invesaro

Stocks Industrials VNOV

OTC · Industrials

VitaNova Life Sciences Corp (VNOV)

VitaNova Life Sciences Corp brought in $3.2M of revenue over the twelve months to July 31, 2026, up 22.0% from a year earlier. It posted a net loss of $114.1K. At July 31, 2026 it held $1.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 14, 2026.

Watch VNOV in 60 seconds
Price
$1.38
0.00% on the day · September 25, 2026
52-week range $0.42 to $7.50
Market cap
$11.5M
Revenue (last 12 months)
$3.2M
+22.0% year on year
Net margin
-3.5%

What VitaNova Life Sciences Corp does

VitaNova Life Sciences Corp is registered with the SEC under industry code SIC 5130 (Wholesale-Apparel, Piece Goods & Notions). Its shares trade on OTC under the ticker VNOV.

Revenue and profit by year

Revenue
FY19: $0 $0 FY19FY20: $0 $0 FY20FY21: $0 $0 FY21FY22: $120K $120K FY22FY23: $38K $38K FY23FY24: $570.7K $570.7K FY24FY25: $2.7M $2.7M FY25FY26: $3M $3M FY26
Net income
FY19: -$106.2K -$106.2K FY19FY20: -$72.3K -$72.3K FY20FY21: -$52.1K -$52.1K FY21FY22: $139.7K $139.7K FY22FY23: -$24.2K -$24.2K FY23FY24: $140.9K $140.9K FY24FY25: $850.7K $850.7K FY25FY26: -$37.3K -$37.3K FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$3M$3.6K-$37.3K-$0.00n/a
2025$2.7M$1.2M$850.7K$0.10n/a
2024$570.7K$205.6K$140.9K$0.03n/a
2023$38K-$24.2K-$24.2K$0.00n/a
2022$120K-$13.4K$139.7K$0.07n/a
2021$0-$52.1K-$52.1K-$0.03n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around December 14, 2026.

Estimated from its filing rhythm: 52 weeks after its report of December 15, 2025. Not a date the company has announced. See the report calendar

Where VNOV ranks in Industrials

Revenue$3M
#539 of 587 in Industrials · Bottom 8%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Industrials

Latest SEC filings

What VitaNova Life Sciences Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 14, 2026
    Quarterly report 10-Q · period to July 31, 2026Revenue rose 210% to $321.6K versus the same quarter last year; diluted EPS -$0.01 versus $0.00.
  2. July 29, 2026
    Annual report 10-K · period to April 30, 2026Revenue rose 14% to $3M versus the prior year; diluted EPS -$0.00 versus $0.10.
  3. March 18, 2026
  4. March 16, 2026
    Quarterly report 10-Q · period to January 31, 2026Revenue rose 130% to $709.6K versus the same quarter last year; diluted EPS -$0.01 versus $0.01.
  5. February 25, 2026
  6. January 27, 2026
  7. January 13, 2026
  8. December 15, 2025
    Quarterly report 10-Q · period to October 31, 2025Revenue rose 46% to $427.1K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  9. October 7, 2025
  10. September 12, 2025
    Quarterly report 10-Q · period to July 31, 2025Revenue was $103.9K; diluted EPS was $0.00.

All filings on SEC EDGAR

Questions about VNOV

What does VitaNova Life Sciences Corp do?

VitaNova Life Sciences Corp is registered with the SEC under industry code SIC 5130 (Wholesale-Apparel, Piece Goods & Notions). Its shares trade on OTC under the ticker VNOV.

Is VitaNova Life Sciences Corp profitable?

No. Over the twelve months to July 31, 2026 it reported a net loss of $114.1K on revenue of $3.2M.

How much revenue does VitaNova Life Sciences Corp make?

Over the twelve months to July 31, 2026 VitaNova Life Sciences Corp reported revenue of $3.2M. That is 22.0% more than a year earlier.

When did VitaNova Life Sciences Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on September 14, 2026. It covers the period to July 31, 2026.

Similar companies

Compare VNOV with

Compare VNOV with any company

Follow VNOV

Get an email when VitaNova Life Sciences Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow VNOV: get an email when it files

Where the numbers come from

Financial figures are the values VitaNova Life Sciences Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.